You have 9 free searches left this month | for more free features.

Talazoparib

Showing 51 - 75 of 107

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Worldwide

Terminated
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • Rochester, New York
  • +4 more
Sep 17, 2021

Kinase Inhibitor Targeted Therapies

Not yet recruiting
  • Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib
  • Measurement of drug concentrations
  • Rennes, France
  • +2 more
Nov 7, 2022

Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Trifluridine and Tipiracil Hydrochloride
  • Talazoparib Tosylate
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 2, 2022

Pancreatic Cancer Trial in Belgium, Singapore, United States (Avelumab, Binimetinib, Talazoparib)

Terminated
  • Pancreatic Cancer
  • Fayetteville, Arkansas
  • +17 more
Dec 28, 2021

Cancer, Advanced Solid Tumor Trial in Kettering (lorlatinib, encorafenib + binimetinib, talazoparib)

Recruiting
  • Cancer
  • Advanced Solid Tumor
  • Kettering, Ohio
    Kettering Health Network
Oct 14, 2022

Prostate Cancer Metastatic Trial in Boston (Telaglenastat, Talazoparib)

Not yet recruiting
  • Prostate Cancer Metastatic
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 27, 2021

Advanced Solid Tumors Trial in Worldwide (Talazoparib, Itraconazole, Rifampin)

Completed
  • Advanced Solid Tumors
  • Talazoparib
  • +2 more
  • Budapest, Hungary
  • +6 more
Jun 1, 2021

Pancytopenia Related to PARP Inhibitors (PancytoRIB)

Completed
  • Cancer
  • PARP inhibitor
  • Caen, Basse Normandie, France
    Alexandre Joachim
Sep 16, 2021

Cancer Trial in Worldwide (Talazoparib)

Completed
  • Cancer
  • Talazoparib
  • Alhambra, California
  • +37 more
Jul 26, 2022

Childhood Solid Tumors Trial in Memphis (Talazoparib, Irinotecan, Temozolomide)

Completed
  • Childhood Solid Tumors
  • Talazoparib
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Feb 8, 2021

TNBC - Triple-Negative Breast Cancer Trial in Seoul (Talazoparib, Placebo)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Talazoparib
  • Placebo
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine
Feb 14, 2021

Neuroendocrine Tumors Trial in Melbourne (Talazoparib)

Recruiting
  • Neuroendocrine Tumors
  • Talazoparib
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 20, 2021

Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Ovarian Mass Trial in United States (Laboratory

Completed
  • Fallopian Tube Serous Adenocarcinoma
  • +18 more
  • Laboratory Biomarker Analysis
  • BMN 673
  • Houston, Texas
  • +5 more
Feb 11, 2022

Pulmonary Toxicities Related to PARP Inhibitors (PulmonaRIB)

Recruiting
  • Cancer
  • olaparib, rucaparib, niraparib, talazoparib, veliparib, pamiparib
  • Caen, Basse Normandie, France
    Alexandre Joachim
May 27, 2021

Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)

Recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +5 more
Jan 12, 2023

Ovarian Cancer Trial in Worldwide (Chemotherapy + avelumab followed by avelumab + talazoparib, Chemotherapy followed by

Completed
  • Ovarian Cancer
  • Chemotherapy + avelumab followed by avelumab + talazoparib
  • +2 more
  • Phoenix, Arizona
  • +71 more
Jul 21, 2022

Advanced Solid Tumors Trial in United States (Talazoparib)

Completed
  • Advanced Solid Tumors
  • Talazoparib
  • Alhambra, California
  • +10 more
Feb 5, 2021

Advanced Solid Tumors Trial in Canada, United States (Talazoparib)

Completed
  • Advanced Solid Tumors
  • Talazoparib
  • Fort Wayne, Indiana
  • +9 more
Dec 11, 2020

Locally Advanced or Metastatic Solid Tumors, Genes, BRCA 1 Trial in Worldwide (Avelumab, Talazoparib)

Active, not recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • Genes, BRCA 1
  • Palo Alto, California
  • +89 more
Jan 18, 2023

Ovarian Cancer Trial run by the NCI (BMN 673 (talazoparib))

Terminated
  • Ovarian Cancer
  • BMN 673 (talazoparib)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 5, 2020

Advanced Malignant Pleural or Peritoneal Mesothelioma Trial (Talazoparib)

Not yet recruiting
  • Advanced Malignant Pleural or Peritoneal Mesothelioma
  • Talazoparib
  • (no location specified)
Jul 8, 2020

Advanced Ovarian Cancer, Primary Peritoneal Cancer, Advanced Breast Cancer Trial run by the NCI (BMN 673)

Completed
  • Advanced Ovarian Cancer
  • +3 more
  • BMN 673
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 2, 2021

Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)

Recruiting
  • Endometrial Cancer
  • Atezolizumab - 28 Day Cycle
  • +6 more
  • Duarte, California
  • +13 more
Jun 8, 2022

Adult Solid Tumor, Childhood Solid Tumor, Recurrent Childhood CNS Tumor Trial in United States (Laboratory Biomarker Analysis,

Completed
  • Adult Solid Neoplasm
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +21 more
Mar 1, 2021